Todos Medical Ltd. (TOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 30, 2026
Todos Medical Company Description
Todos Medical Ltd., a vitro diagnostics company, engages in the development of novel blood tests for the early detection of cancer and neurodegenerative disorders.
It offers COVID testing solutions and Provista diagnostics. The company also develops Videssa Breast, a cancer blood test; Lympro, an Alzheimer’s blood test; TolloTest, a 3CL proteaste test; and TBIA, an AI cancer platform.
In addition, it distributes a dietary supplement under the Tollovid name and develops Tollovir, a 3CL protease inhibitor as COVID anti-viral.
The company was incorporated in 2010 and is based in Tel Aviv-Yafo, Israel.
Todos Medical Ltd.

| Country | Israel |
| Founded | 2010 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Gerald Commissiong |
Contact Details
Address: 121 Derech Menachem Begin Tel Aviv, 6701203 Israel | |
| Phone | 972 73 207 7259 |
| Website | todosmedical.com |
Stock Details
| Ticker Symbol | TOMDF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | IL0011392375 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Gerald E. Commissiong | Chief Executive Officer, President and Director |
| Daniel J. Hirsch | Chief Financial Officer and Director |
| Chris Gross | Vice President of Operations |
| Dr. Jorge A. Leon Ph.D. | Chief Science Officer |
| Dr. Paula T. Trzepacz M.D. | Chief Medical Officer of Neurology |
| Dr. Joseph Wee | Managing Director of Singapore |
| Ilanit Halperin CPA | Corporate Controller |